by Emily Ayshford, University of Chicago Creative rendition of SARS-CoV-2 particles (not to scale). Credit: National Institute of Allergy and Infectious Diseases, NIH A new University of Chicago study has found that the drug masitinib may be effective in treating COVID-19. The drug, which has undergone several clinical trials for human conditions but has not yet...
By Sally Robertson, B.Sc. Feb 1 2021 Researchers at the University of California, San Diego, have demonstrated the potential of using green algae to make recombinant viral proteins that could be used in large scale assays to detect antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19)....
by Sonia Fernandez, University of California – Santa Barbara Winter is on its way. And in this year of coronavirus, with it comes the potential for a second wave of COVID-19. Add in flu season and our tendency to head inside and close our windows to the cold, wet weather, and it appears the next several...
Scientists develop a pocket-sized tool for rapidly identifying various mosquito-borne diseases in resource-constrained clinical environments Dengue, zika, and chikungunya viruses are transmitted by mosquitoes and cause tropical fevers with similar symptoms, making accurate diagnosis complicated. Now, researchers from Gwangju Institute of Science and Technology in Korea have developed a simple and low-cost diagnostic platform—a lab-on-paper strip—that can...
